eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2000
vol. 4
 
Share:
Share:
abstract:

The use of erythropoietin in cancer patients receiving radiation therapy

Dariusz M. Kowalski
,
Katarzyna Zajda
,
Maciej Krzakowski
,
Piotr Jaśkiewicz

Współcz Onkol (2000) 1, 25-29
Online publish date: 2003/07/25
View full text Get citation
 
Anaemia is common in the course of malignancy. In approximately 20-60 % of patients anaemia is a significant clinical complication. The paper presents etiology and pathogenesis of anaemia in patients with neoplastic diseases. The characteristics and effects of erythropoietin are reviewed. The results of randomised clinical trials on the use of erythropoietin in cancer patients treated with radiotherapy and radiochemotherapy are presented.
keywords:

erythropoietin, anaemia, hemoglobine, malignant disease, radiation therapy, chemotherapy

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.